Skip to main content
. 2022 Apr 27;13:875887. doi: 10.3389/fphar.2022.875887

TABLE 4.

Lymphoid populations (relative abundance) in the lung of SP-CI73TGATA1WT and SP-CI73TGATA1KO mice.

Lymphoid Genotype CTL (n=6) 7d (n=5) 14d (n=4) 42d (n=4)
Total Lymphocytes CD3+ SPCI73TGATA1WT 17.33 ± 1.36 9.71 ± 2.54 a 6.43 ± 1.51 a 20.97 ± 1.14 b , c
SPCI73TGATA1KO 12.51 ± 0.85 14.58 ± 3.08 15.27 ± 1.56 21.32 ± 1.26a
T Cells CD3+CD4+ SPCI73TGATA1WT 9.50 ± 0.60 3.64 ± 0.87 a 2.29 ± 0.42 a 9.20 ± 0.55 b , c
SPCI73TGATA1KO 4.96 ± 0.44 6.51 ± 1.48 7.90 ± 1.42 10.98 ± 0.91 a , b
T Cells CD3+CD8+ SPCI73TGATA1WT 0.89 ± 0.16 1.10 ± 0.28 0.22 ± 0.03 3.05 ± 1.20 a , c
SPCI73TGATA1KO 1.77 ± 0.20 1.48 ± 0.23 0.85 ± 0.27 1.64 ± 0.17
Dendritic Cells CD4+CD103+ SPCI73TGATA1WT 0.23 ± 0.02 0.21 ± 0.04 0.92 ± 0.40 0.62 ± 0.14
SPCI73TGATA1KO 0.10 ± 0.01 0.81 ± 0.41 0.73 ± 0.14 0.84 ± 0.07
Dendritic Cells CD8+CD103+ SPCI73TGATA1WT 3.36 ± 0.41 2.41 ± 0.80 0.42 ± 0.11 a 4.78 ± 0.09 b , c
SPCI73TGATA1KO 1.87 ± 0.32 2.69 ± 0.58 1.28 ± 0.33 3.38 ± 0.39 c
Total B Cells B220+ SPCI73TGATA1WT 20.06 ± 2.95 7.38 ± 3.07 a 3.22 ± 1.15 a 18.64 ± 1.56 b , c
SPCI73TGATA1KO 28.35 ± 2.07 12.07 ± 4.08 a 9.42 ± 1.68 a 13.67 ± 1.18 a
B Cells B220+CX3CR1- SPCI73TGATA1WT 8.03 ± 1.60 2.06 ± 0.90 a 1.93 ± 0.59 a 7.49 ± 1.01 b , c
SPCI73TGATA1KO 8.17 ± 0.49 4.66 ± 1.93 1.71 ± 0.55 a 1.84 ± 0.17 a
B Cells B220+CX3CR1+ SPCI73TGATA1WT 12.03 ± 2.01 5.32 ± 2.19 1.29 ± 0.63 a 11.15 ± 0.70 c
SPCI73TGATA1KO 20.18 ± 1.66 7.42 ± 2.27 a 5.47 ± 2.09 a 11.83 ± 1.07 a

Single cell suspensions of SP-CI73TGATA1WT and SP-CI73TGATA1KO lung digests was assessed by flow cytometry, enriched in viable CD45+ singlets, and analyzed following gating strategy described in the Methods section. Relative abundance (%) is presented as means ± SEM (N=4-6 mice/condition). Data were analyzed by two-way ANOVA, with Tukey post-hoc test.

a

Significant compared to controls (CTL).

b

Significant compared to 7 d group.

c

Significant compared to14 d group.